NSPR Stock Earnings InspireMD Beats EPS, Beats Revenue for Q4 2023
| NSPR Stock | USD 2.77 0.06 2.21% |
Slightly above 55% of InspireMD's retail investors are presently thinking to get in. The analysis of overall sentiment of trading InspireMD stock suggests that some investors are interested at this time. InspireMD's investing sentiment overview a quick insight into current market opportunities from investing in InspireMD. Many technical investors use InspireMD stock news signals to limit their universe of possible portfolio assets and to time the market correctly.
InspireMD |
NSPR stock results show that InspireMD beat analyst estimates for earnings per share and beat on revenue for the fourth quarter of 2023.
Read at investorplace.com
 |
InspireMD Fundamental Analysis
We analyze InspireMD's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of InspireMD using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of InspireMD based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Return On Equity
Return On Equity Comparative Analysis
InspireMD is currently under evaluation in return on equity category among its peers. Return on Equity or ROE tells company stockholders how effectually their money is being utilized or reinvested. It is a useful ratio when analyzing company profitability or the management effectiveness given the capital invested by the shareholders. ROE shows how efficiently a company utilizes investments to generate income.
InspireMD Potential Pair-trading
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with InspireMD stock to make a market-neutral strategy. Peer analysis of InspireMD could also be used in its relative valuation, which is a method of valuing InspireMD by comparing valuation metrics with similar companies.
Peers
InspireMD Related Equities
| SSKN | STRATA Skin | 0.99 | ||||
| RPID | Rapid Micro | 0.97 | ||||
| VVOS | Vivos Therapeutics | 0.46 | ||||
| SGHT | Sight Sciences | 0.30 | ||||
| SRDX | SurModics | 0.05 | ||||
| IRIX | IRIDEX | 1.11 | ||||
| RSLS | ReShape Lifesciences | 3.07 | ||||
| NPCE | Neuropace | 3.30 | ||||
| LNSR | LENSAR | 3.47 | ||||
| NUWE | Nuwellis | 3.60 | ||||
| TIVC | Tivic Health | 6.45 | ||||
| BBLG | Bone Biologics | 8.18 | ||||
| BJDX | Bluejay Diagnostics | 8.83 | ||||
| TNON | Tenon Medical | 12.32 | ||||
| AIMD | Ainos | 13.64 |
Additional Tools for InspireMD Stock Analysis
When running InspireMD's price analysis, check to measure InspireMD's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy InspireMD is operating at the current time. Most of InspireMD's value examination focuses on studying past and present price action to predict the probability of InspireMD's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move InspireMD's price. Additionally, you may evaluate how the addition of InspireMD to your portfolios can decrease your overall portfolio volatility.